Doctors Note Logo

Published on: 9/24/2026

Is paroxetine used to treat hot flashes in menopause?

Yes, paroxetine is used to treat hot flashes, and low-dose paroxetine mesylate (7.5 mg) is the only non-hormonal prescription medication FDA-approved for moderate to severe vasomotor symptoms of menopause, while higher-dose paroxetine hydrochloride is sometimes prescribed off-label. Studies show it can meaningfully reduce the frequency and severity of hot flashes and night sweats within a few weeks, making it an option for people who cannot or prefer not to use hormone therapy. Important cautions apply, including a significant interaction with tamoxifen, potential side effects such as nausea, fatigue, headache, and sexual dysfunction, and the need to taper rather than stop abruptly, so there are several factors to consider before starting it. See below to understand dosing, effectiveness, risks, and how paroxetine compares with other treatments.

Because hot flashes can also stem from thyroid disease, certain medications, infections, or other conditions that look similar to menopause, it is worth taking a free, instant, online symptom check to clarify what may be driving your symptoms and to walk into your next appointment ready with the right questions.

Last reviewed for medical accuracy: 09/24/2026

answer background

Explanation

Paroxetine and Hot Flashes in Menopause

Menopause often brings vasomotor symptoms—most notably, hot flashes and night sweats—that can disrupt daily life. While hormone therapy is a common first-line treatment, not everyone can or wants to use estrogen. For these women, certain antidepressants—including paroxetine—offer an alternative.

What Is Paroxetine?
Paroxetine is a selective serotonin reuptake inhibitor (SSRI) originally approved to treat depression, anxiety disorders and obsessive-compulsive disorder. It works by increasing serotonin levels in the brain, which can help stabilize temperature regulation centers.

Paroxetine for Hot Flashes: The Evidence
• FDA approval: In 2013, the U.S. Food and Drug Administration approved low-dose paroxetine mesylate 7.5 mg (Brisdelle®) specifically for moderate-to-severe hot flashes in menopause.
• Clinical trials: Studies show low-dose paroxetine reduces hot flash frequency by 33–65% compared to placebo.
• Off-label use: Higher doses of paroxetine (e.g., paroxetine 40 mg) have not been formally approved for hot flashes, but some clinicians prescribe them off-label, drawing on depression/anxiety data and anecdotal experience.

Why Not Stick to 7.5 mg?
Using paroxetine 40 mg for hot flashes may seem attractive based on its known safety profile in mood disorders, but higher doses can increase risk of side effects. Common side effects tend to be dose-related:

• Nausea
• Drowsiness or insomnia
• Dry mouth
• Sexual dysfunction
• Weight changes

Before increasing beyond 7.5 mg, it’s important to discuss benefits and risks with your doctor.

Who Might Consider Paroxetine 40 mg Off-Label?
While most women start with low-dose paroxetine, a doctor may consider paroxetine 40 mg in women who:

  • Have tried 7.5 mg without adequate relief
  • Have concurrent depression or anxiety needing higher SSRI doses
  • Prefer a single medication to address both mood and hot flashes

Dosage and Administration
• Typical starting dose for hot flashes: 7.5 mg at bedtime
• Titration: If side effects are minimal but relief is insufficient, a physician may gradually increase the dose.
• Off-label use: When targeting both mood and vasomotor symptoms, doses up to 40 mg daily can be prescribed—but always under close medical supervision.

Monitoring and Safety
• Regular follow-up: Evaluate hot flash frequency, mood, sleep, and side effects every 4–6 weeks after dose changes.
• Watch for serotonin syndrome: Though rare, combining paroxetine with other serotonergic drugs (e.g., triptans, other SSRIs, St. John’s wort) can increase risk. Symptoms include agitation, rapid heartbeat and fever.
• Gradual taper: If you and your doctor decide to stop paroxetine, taper slowly over weeks to avoid withdrawal symptoms such as dizziness, irritability or “brain zaps.”

Alternatives to Paroxetine
If paroxetine—at any dose—doesn’t suit you, consider:
• Other SSRIs or SNRIs (e.g., venlafaxine)
• Gabapentin or pregabalin
• Non-hormonal lifestyle measures (cooling techniques, loose clothing)
• Complementary therapies (acupuncture, mindfulness)

When to Seek Personalized Guidance
Every woman’s experience of menopause is unique. If you’re unsure whether paroxetine 40 mg or another treatment is right for you, you might consider a free, online symptom check, using the doctor approved Ubie Symptom Checker.

This tool can help you:

  • Clarify your symptoms
  • Understand possible treatment paths
  • Prepare questions for your healthcare provider

Speak to a Doctor
Hot flashes can range from mildly inconvenient to severely disruptive. If you experience:
• Very frequent or intense hot flashes
• Chest pain, shortness of breath or fainting
• Any new or worsening mental health symptoms

—please speak to a doctor right away. Only a healthcare professional can determine whether paroxetine 40 mg or another treatment is safe and appropriate for you.

Key Takeaways
• Low-dose paroxetine mesylate 7.5 mg is FDA-approved for hot flashes; paroxetine 40 mg is used off-label primarily when depression or anxiety coexists.
• Higher doses may improve symptom relief but carry increased side-effect risk.
• Regular monitoring and gradual tapering are essential.
• Alternatives include other medications, lifestyle changes and non-drug therapies.
• For personalized guidance, consider a free, online symptom check, using the doctor approved Ubie Symptom Checker.

Always discuss any treatment changes or concerns—including potential life-threatening symptoms—with your doctor.

(References)

  • * Nelson HD. Menopause. Lancet. 2008 Mar 1;371(9614):760-70. doi: 10.1016/S0140-6736(08)60346-3. PMID: 18313505.

  • * Mahon SM, Kaplan M. Paroxetine approval. Am J Nurs. 2014 Jan;114(1):10. doi: 10.1097/01.NAJ.0000441774.81603.dd. PMID: 24370506.

  • * Portman DJ, Kaunitz AM, Kazempour K, Mekonnen H, Bhaskar S, Lippman J. Effects of low-dose paroxetine 7.5 mg on weight and sexual function during treatment of vasomotor symptoms associated with menopause. Menopause. 2014 Oct;21(10):1082-90. doi: 10.1097/GME.0000000000000210. PMID: 24552977; PMCID: PMC4175016.

  • * Hill DA, Crider M, Hill SR. Hormone Therapy and Other Treatments for Symptoms of Menopause. Am Fam Physician. 2016 Dec 1;94(11):884-889. PMID: 27929271.

  • * Shrestha P, Fariba KA, Abdijadid S. Paroxetine. 2023 Jan. PMID: 30252278.

  • * Crandall CJ, Mehta JM, Manson JE. Management of Menopausal Symptoms: A Review. JAMA. 2023 Feb 7;329(5):405-420. doi: 10.1001/jama.2022.24140. PMID: 36749328.

  • * Fezolinetant (Veozah) for menopausal vasomotor symptoms. Med Lett Drugs Ther. 2023 Jun 26;65(1679):97-99. doi: 10.58347/tml.2023.1679a. PMID: 37339088.

  • * Morga A, Ajmera M, Gao E, Patterson-Lomba O, Zhao A, Mancuso S, Siddiqui E, Kagan R. Systematic review and network meta-analysis comparing the efficacy of fezolinetant with hormone and nonhormone therapies for treatment of vasomotor symptoms due to menopause. Menopause. 2024 Jan 1;31(1):68-76. doi: 10.1097/GME.0000000000002281. Epub 2023 Nov 27. PMID: 38016166; PMCID: PMC11812669.

  • * Drugs for menopausal symptoms. Med Lett Drugs Ther. 2024 Mar 4;66(1697):33-38. doi: 10.58347/tml.2024.1697a. PMID: 38412276.

  • * Goyal A, Ekelmans A, Cerjak J, Frishman WH. Nonhormonal Treatment of Vasomotor Symptoms of Menopause. Cardiol Rev. 2025 Mar 6. doi: 10.1097/CRD.0000000000000874. Epub 2025 Mar 6. PMID: 40047411.

Thinking about asking ChatGPT?Ask me instead

Tell your friends about us.

We would love to help them too.

smily Shiba-inu looking

For First Time Users

What is Ubie’s Doctor’s Note?

We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.

Was this page helpful?

Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.